Skip to main content
OpenTrials
Completed

NCT Number: NCT00456729

Malabsorption as a Cause of Iron Treatment Failure in Infants

Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–4 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center

Afula, 18101, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All infants referred to the Pediatric Hematology Unit because lack of response to iron treatment.

Exclusion criteria

  • Patients diagnosed with specific malabsorption causes like Celiac or Cystic Fibrosis.

Treatment and study plan

Metronidazole

Drug

Blood tests

Procedure

Primary outcomes

  1. Hgb level

Secondary outcomes

  1. Iron level

  2. Ferritin Level

Sponsors and collaborators

Lead sponsor

HaEmek Medical Center, Israel

Other

Registry information

Official study title

Malabsorption as a Cause of Iron Treatment Failure in Infants - A Clinical Observational Study

Important dates

Study start
2006
Study completion
2006
First posted
Apr 5, 2007
Registry last updated
Apr 5, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.